1. Home
  2. CSWC vs EVO Comparison

CSWC vs EVO Comparison

Compare CSWC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capital Southwest Corporation

CSWC

Capital Southwest Corporation

N/A

Current Price

$21.72

Market Cap

1.3B

ML Signal

N/A

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$2.43

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CSWC
EVO
Founded
1961
1993
Country
United States
Germany
Employees
30
4766
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CSWC
EVO
Price
$21.72
$2.43
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$23.50
$7.00
AVG Volume (30 Days)
577.3K
127.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
11.63%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.83
N/A
Revenue Next Year
$10.26
$7.13
P/E Ratio
$12.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.47
$2.48
52 Week High
$23.84
$4.80

Technical Indicators

Market Signals
Indicator
CSWC
EVO
Relative Strength Index (RSI) 36.18 23.63
Support Level $21.37 N/A
Resistance Level $23.06 $3.78
Average True Range (ATR) 0.54 0.10
MACD -0.09 -0.10
Stochastic Oscillator 20.25 0.00

Price Performance

Historical Comparison
CSWC
EVO

About CSWC Capital Southwest Corporation

Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: